The AAMC joined nearly 125 signatories representing patients, providers, and public health organizations in an April 21 letter to congressional leaders urging legislative efforts to eliminate hepatitis C.
The organizations noted that an oral medication is available that cures over 95% of cases in 12 weeks or less and that the president’s fiscal year (FY) 2024 budget proposed a program to develop point-of-care diagnostics and support opportunities to broaden treatment access. The Biden administration has also proposed increased investments in vaccine research to prevent future hepatitis C infections. The letter requested that Congress develop and pass legislation to authorize this hepatitis C elimination plan immediately.